Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?

MeSH terms

• Age Factors
• Child
• Cyclophosphamide / administration & dosage*
• Cyclophosphamide / adverse effects
• Drug Administration Schedule
• Female
• Glucocorticoids / administration & dosage*
• Glucocorticoids / adverse effects
• Humans
• Immunosuppressive Agents / administration & dosage*
• Immunosuppressive Agents / adverse effects
• Kidney / drug effects*
• Kidney / physiopathology
• Male
• Nephrotic Syndrome / diagnosis
• Nephrotic Syndrome / drug therapy*
• Nephrotic Syndrome / physiopathology
• Prednisolone / administration & dosage*
• Prednisolone / adverse effects
• Recurrence
• Remission Induction
• Ribonucleosides / administration & dosage
• Risk Assessment
• Risk Factors
• Rituximab / administration & dosage*
• Rituximab / adverse effects
• Time Factors
• Treatment Outcome